Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 968 clinical trials
featured
Albuterol in Patients With Lymphangioleiomyomatosis

Background: Lymphangioleiomyomatosis (LAM) is a rare type of lung disease that occurs almost exclusively in women. In LAM, muscle tissue grows in the lungs and starts to block the flow of air. It is a progressive disease, and in severe cases may require a lung transplant. One possible treatment to …

lymphangioleiomyomatosis
  • 16 views
  • 22 Dec, 2020
  • 1 location
featured
A Phase III Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine over 24 Weeks in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease.

This study will enroll approximately 800 patients with moderate to severe COPD in 2 subsets. The 24-week subset will enroll approximately 400 patients randomized 1:1 ensifentrine (3 mg): placebo and the 48-week subset will enroll approximately 400 patients randomized 3:1 in order to minimize the number of patients assigned to …

  • 156 views
  • 23 Nov, 2020
  • 1 location
featured
COPD Exacerbation Research Study

Looking for patients at least 40 years of age who have been diagnosed with COPD and recently had several events of worsening of symptoms.  

  • 57 views
  • 23 Nov, 2020
  • 1 location
featured
A Washington University research study is currently enrolling participants with COPD.

The study will last approximately 68 weeks. There will be study visits every 2 to 4 weeks (1 to 3 hours each). Participation includes physical exam, blood and urine tests, COPD assessment, spirometry (breathing test), questionnaires, and chest imaging. Compensation is provided for time and effort. Costs for COPD controller …

COPD
pulmonary diseases
pulmonary disease
chronic obstructive pulmonary disease (copd)
chronic obstructive pulmonary disease
  • 0 views
  • 12 Jan, 2021
  • 1 location
featured
NO 0050-0637

ICON Early Phase Services is conducting a non-interventional device research study adults age 40+ who are either healthy, or, have chronic obstructive pulmonary disease (COPD). This study is being done to test the potential of using devices to help manage disease symptoms. Participants will complete a screening visit to determine …

  • 105 views
  • 23 Nov, 2020
  • 1 location
featured
COPD Research Study for those with currently using inhaled medications (triple therapy) and have required an oral steroid for a flare in breathing 1-2 times in the last 12 months.

This investigational study is enrolling moderate to severe COPD subjects.   To qualify you must be on inhaled maintenance medications and have required oral steroids 1-2 times or a hospitalization in the last year.    Pulmonary function test will be performed and compensation will be provided for those who qualify.  

  • 76 views
  • 23 Nov, 2020
  • 1 location
featured
A Prospective, Multi-Center, Randomized, Controlled, Pivotal Trial to Validate the Safety and Efficacy of the Hemolung® Respiratory Assist System for COPD Patients Experiencing an Acute Exacerbation Requiring Ventilatory Support (Protocol No. HL-CA-5000)

A Prospective, Multi-Center, Randomized, Controlled, Pivotal Trial to Validate the Safety and Efficacy of the Hemolung® Respiratory Assist System for COPD Patients Experiencing an Acute Exacerbation Requiring Ventilatory Support (Protocol No. HL-CA-5000)  

  • 36 views
  • 11 Jun, 2020
  • 1 location
featured
The AIRWISE Study: Assessment In a Real World setting of the effect of Inhaled Steroid-based triple therapy versus the combination of tiotropium and olodaterol on reducing COPD Exacerbations

Patients diagnosed with COPD will be approached and asked to complete Questionnaires. These questionnaires will help guide the sponsor as to what patients thinks which works better, being on triple therapy or combo therapy when dealing with COPD and exacerbations  

  • 54 views
  • 11 Jun, 2020
  • 1 location
featured
Phase III, Double Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Etrolizumab During Induction and Maintenance in Patients With Moderate to Severe Active Ulcerative Colitis Who Are Refractory to or Intolerant of TNF Inhibitors

Phase III, Double Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Etrolizumab During Induction and Maintenance in Patients With Moderate to Severe Active Ulcerative Colitis Who Are Refractory to or Intolerant of TNF Inhibitors

  • 182 views
  • 23 Nov, 2020
  • 1 location
featured
Research study for volunteers at least 18 years of age who are currently experiencing symptoms of chronic constipation

Research study for volunteers at least 18 years of age who are currently experiencing symptoms of chronic constipation

  • 212 views
  • 08 Nov, 2020
  • 1 location